Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.

Abstract

For dysthymia, paroxetine and PST-PC improved remission compared with placebo plus nonspecific clinical management. Results varied for the other outcomes measured. For minor depression, the 3 interventions were equally effective; general clinical management (watchful waiting) is an appropriate treatment option.